TM9SF1 as a Novel Prognostic Biomarker for Sepsis Severity and Mortality: A Longitudinal Study.

TM9SF1 作为脓毒症严重程度和死亡率的新型预后生物标志物:一项纵向研究

阅读:4
作者:Wang Ke, Zhang Lu, Zhou Fengqiao, Zhao Zhenwang, Liu Mingming, Huang Min, Liu Yang, Qiu Guangyu, Shen Xiaofang, Xiao Hong, Cao Fengsheng, Chen Huabo, Xiao Juan
BACKGROUND: Sepsis is a prevalent and detrimental condition in intensive care units (ICUs) and a leading cause of mortality. The present study evaluated the role and clinical importance of Transmembrane 9 superfamily member 1 (TM9SF1) as a potential indicator for the early detection of sepsis severity and prognosis. METHODS: This study included 118 patients with septic shock and 107 patients with sepsis, all of whom underwent follow-up assessments. Gene expression of TM9SF1 and cytokines in peripheral blood mononuclear cells (PBMCs) were quantified using qPCR. The predictive role of TM9SF1 was compared with standard clinical markers using receiver operating characteristic (ROC) curve analysis. A nomogram-based predictive model with TM9SF1 was constructed to enable early detection of disease severity and mortality in sepsis patients. RESULTS: TM9SF1 mRNA expression was considerably elevated in the septic shock group relative to the sepsis group and healthy controls (p < 0.001). Increased TM9SF1 levels were associated with higher sepsis severity (OR = 3.29, 95% CI = 1.88-5.78, p < 0.001) and mortality (HR = 11.12, 95% CI = 4.35-28.45, p < 0.001). Moreover, ROC curve analysis showed that TM9SF1 outperformed clinical indicators in predicting sepsis severity and mortality including CRP, oxygenation index and lactate. A nomogram model comprised TM9SF1, CRP, D-dimer, and ESR and predicted sepsis severity (AUC = 0.883, 95% CI = 0.839-0.927), while another model with TM9SF1, CRP, ESR, lactate and oxygenation index predicted patient's mortality (C-index = 0.931; 95% CI = 0.884-0.978). CONCLUSION: The study concluded that both sepsis severity and mortality were found to increase with higher TM9SF1 levels, suggesting that TM9SF1 has a crucial role in regulating inflammation in sepsis patients by controlling cytokine production. It can serve as a potential novel immune biomarker for the early detection of disease progression and clinical findings in sepsis patients.

特别声明

1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。

2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。

3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。

4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。